Garetosmab

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Garetosmab (REGN 2477) 是一种全人 IgG4 单克隆抗体，可特异性抑制激活素 A (activin A)。Garetosmab 可用于进行性骨化性纤维发育不良 (FOP) 的研究。

Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research.

Garetosmab (REGN 2477) specifically binds to and blocks signaling of activin proteins containing the inhibin βα subunit (activins A, AB, and AC). In vitro, Garetosmab has high affinity and specificity for activins A, AB, and AC, but does not bind or functionally inhibit other TGF-β family ligands that share the same activin receptor pathways, including activin B, inhibin A, BMP-2, BMP6, BMP9, BMP10, GDF8, and GDF11.

——

——

Others

Other Targets

TGF-beta/Smad

——

——

2097125-54-5

——

>98% (HPLC)

——

——

——

(-20℃)

With Ice Pack

≥ 2 years